Pennsylvania HB916 amends the Childhood Blood Lead Test Act to enhance lead poisoning prevention, assessment, and testing for children and pregnant.
Pennsylvania HB916 amends the Childhood Blood Lead Test Act to strengthen lead poisoning prevention, assessment, and testing for children and pregnant women. The bill mandates that health care providers consider possible lead exposure and perform blood lead testing for children by 24 months of age or between 24 and 72 months if never tested. For pregnant women, testing is required if a single risk factor is identified. Health insurance policies and government programs must cover blood lead tests for children under 72 months and pregnant women.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.